Dose-Dependent Anti-Inflammatory Effects of Live and Heat-Treated Ligilactobacillus salivarius and Bifidobacterium breve via NF-κB and COX-2 Modulation in an In Vitro Model of Airway Inflammation
Nutrients · 2025
DOI: 10.3390/nu17152504 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Marta Pagnini und 6 weiteren Autor:innen. Beteiligte Einrichtung: Dipartimento di Patologia Chirurgica, Medica, Molecolare e dell'Area Critica, University of Pisa, 56126 Pisa, Italy. Hauptthemen laut MEDLINE: Probiotics, Bifidobacterium breve, NF-kappa B, Cyclooxygenase 2. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Probiotical (Italy), Probiotical S.p.A..
Abstract (Originalsprache)
Background
Probiotics are live microorganisms known for their health-promoting effects, particularly in modulating immune responses and reducing inflammation within the gastrointestinal tract. Emerging evidence suggests probiotics may also influence respiratory health, prompting investigation into their potential therapeutic application in lung inflammation.
Methods
This study examined the anti-inflammatory effects of Ligilactobacillus salivarius (LS01 DSM 22775) and Bifidobacterium breve (B632 DSM 24706) on inflamed pulmonary epithelial cells. Lung carcinoma epithelial cells (A549) and normal bronchial epithelial cells (16HBE) were stimulated with IL-1β and treated with viable and heat-treated probiotics.
Results
CCL-2 levels were significantly reduced by up to 40%, in A549 by viable form (105–107 AFU/g), instead of in 16HBE by heat-treated form (107–109 TFU/g). In A549 cells, TNF-α decreased by 20–80% with all formulations; instead, in 16HBE cells, IL-8 was reduced by viable strains (107 AFU/g) by approximately 50%, while heat-treated strains (109 TFU/g) decreased both IL-6 and IL-8 by 50%. All effective treatments completely inhibited IL-4 and eotaxin and suppressed NF-κB activation in both cell lines, with up to 80% reduction in phospho-p65 levels. In A549 cells, heat-treated strains fully blocked PGE2 production; instead, all four probiotics significantly inhibited COX-2 expression by approximately 50%.
Conclusions
These findings demonstrate that both viable and heat-treated probiotics can modulate inflammatory responses in pulmonary epithelial cells, suggesting their potential application in inflammatory respiratory diseases. Heat-treated formulations may be particularly suited for local administration via inhalation, offering a promising strategy for targeting airway inflammation directly.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dipartimento di Patologia Chirurgica, Medica, Molecolare e dell'Area Critica, University of Pisa, 56126 Pisa, Italy.
- Centro Dipartimentale di Biologia Cellulare Cardiorespiratoria, University of Pisa, 56126 Pisa, Italy.
- Research and Development, Probiotical Research, 28100 Novara, Italy.
ORCID-Profile: Annalisa Visciglia, Marco Pane, Alessandro Celi, Angela Amoruso, Tommaso Neri
Förderung
- Probiotical (Italy)
- Probiotical S.p.A.
Zitieren
APA
Pagnini, M., Visciglia, A., Deusebio, G., Pane, M., Celi, A., Amoruso, A., & Neri, T. (2025). Dose-Dependent Anti-Inflammatory Effects of Live and Heat-Treated Ligilactobacillus salivarius and Bifidobacterium breve via NF-κB and COX-2 Modulation in an In Vitro Model of Airway Inflammation. Nutrients. https://doi.org/10.3390/nu17152504
Vancouver
Pagnini M, Visciglia A, Deusebio G, Pane M, Celi A, Amoruso A, et al. Dose-Dependent Anti-Inflammatory Effects of Live and Heat-Treated Ligilactobacillus salivarius and Bifidobacterium breve via NF-κB and COX-2 Modulation in an In Vitro Model of Airway Inflammation. Nutrients. 2025. doi:10.3390/nu17152504
BibTeX
@article{Pagnini2025,
author = {Pagnini, Marta and Visciglia, Annalisa and Deusebio, Giovanni and Pane, Marco and Celi, Alessandro and Amoruso, Angela and Neri, Tommaso},
title = {Dose-Dependent Anti-Inflammatory Effects of Live and Heat-Treated Ligilactobacillus salivarius and Bifidobacterium breve via NF-κB and COX-2 Modulation in an In Vitro Model of Airway Inflammation},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17152504}
}
EUVIMED